Clinical Trial Update: A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Aliskiren in elderly patients with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED